We showed that NDRG4 hypermethylation in primary breast tumors is associated with reduced NDRG4 protein expression and worse prognostic factors, such as tumor size, p53 overexpression and the presence of lymph node metastasis. The gene discussed is TP53; the disease is metastatic malignant neoplasm in the lymph nodes.